Hemostatic abnormalities in COVID-19: A guided review
Abstract The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has already taken on pandemic proportions, affecting over 213 countries in a matter of weeks. In this context, several studies correlating hemostatic disorders with the infection dynamics of the new coronavirus have emerged. These studies have shown that a portion of the patients affected by Coronavirus Disease 2019 (COVID-19) have prolonged prothrombin time (PT) and activated partial thromboplastin time (APTT), elevated D-dimer levels and other fibrinolytic products, antithrombin (AT) activity reduced and decrease of platelet count. Based on these hallmarks, this review proposes to present possible pathophysiological mechanisms involved in the hemostatic changes observed in the pathological progression of COVID-19. In this analysis, it is pointed the relationship between the downregulation of angiotensin-converting enzyme 2 (ACE2) and storm cytokines action with the onset of hypercoagulability state, other than the clinical events involved in thrombocytopenia and hyperfibrinolysis progression.
| Main Author: | |
|---|---|
| Format: | Digital revista |
| Language: | English |
| Published: |
Academia Brasileira de Ciências
2020
|
| Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652020000700905 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|